Results 21 to 30 of about 36,439 (252)

Some construction of group divisible designs with singer groups

open access: yesDiscrete Mathematics, 1991
An MDS is a \((v,k,\lambda)\)-difference set with \(v=4(k-\lambda)\); then there exist an integer \(u\) such that \(v=4u^2\). A \((m,n,k,\lambda_1,\lambda_2)\)-DDS has the property \((M)\) if \(mn=4(k-\lambda_2)\). The case \(\lambda_1=0\) is characterized.
K. T. Arasu 0001, Alexander Pott
openaire   +1 more source

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges   +12 more
wiley   +1 more source

Research on fractional repetition codes based on group divisible designs

open access: yesTongxin xuebao, 2015
A novel design of FR (fractional repetition) codes was proposed which aims at providing efficient repair at the minimum bandwidth regenerating point.The design consisted of an outer MDS (maximum distance separable) code and an inner repetition code ...
Bing ZHU   +4 more
doaj   +2 more sources

q-analogs of group divisible designs [PDF]

open access: yes, 2018
A well known class of objects in combinatorial design theory are {group divisible designs}. Here, we introduce the $q$-analogs of group divisible designs.
Buratti, Marco   +4 more
core   +2 more sources

Nearly Optimal Sparse Group Testing

open access: yes, 2018
Group testing is the process of pooling arbitrary subsets from a set of $n$ items so as to identify, with a minimal number of tests, a "small" subset of $d$ defective items.
Gandikota, Venkata   +3 more
core   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Distance-regular Cayley graphs with small valency

open access: yes, 2019
We consider the problem of which distance-regular graphs with small valency are Cayley graphs. We determine the distance-regular Cayley graphs with valency at most $4$, the Cayley graphs among the distance-regular graphs with known putative intersection ...
Jazaeri, Mojtaba, van Dam, Edwin R.
core   +1 more source

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine   +14 more
wiley   +1 more source

Preferences of Pediatric Patients and Their Caregivers for Chemotherapy‐Induced Nausea and Vomiting Control Endpoints: A Mixed Methods Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Although not always achieved, complete chemotherapy‐induced nausea and vomiting (CINV) control is the conventional goal of CINV prophylaxis. In this two‐center, mixed‐methods study, we sought to understand the preferences of adolescent patients and family caregivers for CINV control endpoints.
Haley Newman   +8 more
wiley   +1 more source

Intravitreal GD2‐Specific Chimeric Antigen Receptor T‐Cell Therapy for Refractory Retinoblastoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Effective treatments for advanced, treatment‐resistant retinoblastoma (RB) remain limited. GD2‐specific chimeric antigen receptor (CAR) T cells show potent antitumor activity with minimal toxicity but have not previously been evaluated in RB.
Subongkoch Subhadhirasakul   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy